Prudential Financial
AMRI

Prudential Financial’s Albany Molecular Research Inc AMRI Stock Holding History

Prudential Financial’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-37,770
Closed -$820K – 2407
2017
Q2 		$820K Sell
37,770
-450
-1% -$8.17K ﹤0.01% 1902
2017
Q1 		$536K Sell
38,220
-250
-0.6% -$4.09K ﹤0.01% 2019
2016
Q4 		$722K Sell
38,470
-1,170
-3% -$19.9K ﹤0.01% 1930
2016
Q3 		$654K Sell
39,640
-26,080
-40% -$386K ﹤0.01% 1932
2016
Q2 		$883K Buy
65,720
+1,620
+3% +$23.6K ﹤0.01% 1872
2016
Q1 		$980K Buy
64,100
+1,700
+3% +$26.6K ﹤0.01% 1821
2015
Q4 		$1.24M Buy
62,400
+1,500
+2% +$28.5K ﹤0.01% 1708
2015
Q3 		$1.06M Buy
60,900
+5,700
+10% +$116K ﹤0.01% 1728
2015
Q2 		$1.12M Buy
55,200
+1,100
+2% +$21.2K ﹤0.01% 1775
2015
Q1 		$952K Buy
54,100
+1,000
+2% +$17K ﹤0.01% 1842
2014
Q4 		$864K Buy
53,100
+700
+1% +$12.8K ﹤0.01% 1786
2014
Q3 		$1.16M Buy
52,400
+6,600
+14% +$135K ﹤0.01% 1672
2014
Q2 		$921K Buy
+45,800
New +$776K ﹤0.01% 1837

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Prudential Financial's AMRI Position: Q3 2017 in Review

Prudential Financial sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 37,770 shares — an estimated $820K sold.

Prudential Financial first reported a position in AMRI in Q2 2014 and held it in 13 quarters. The position peaked at $1.24M in Q4 2015. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Prudential Financial reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Prudential Financial sold 37,770 Albany Molecular Research Inc shares in Q3 2017, an estimated $820K.
  • Prudential Financial first reported a position in Albany Molecular Research Inc in Q2 2014 and held it in 13 quarters.
  • Prudential Financial's Albany Molecular Research Inc position peaked at $1.24M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Prudential Financial's 13F filing for Q3 2017, filed 2 Nov 2017.